| PALVELLA THERAPEUTICS NEW |
| USA |
| Gesundheit |
| US6979471090 / A40RA6 |
| PI6 (Frankfurt) / PVLA (NASDAQ) |
| FRA:PI6, ETR:PI6, PI6:GR, NASDAQ:PVLA |
| - |
| https://palvellatx.com/ |
|
Palvella Therapeutics Inc is a pharmaceutical company committed to the development of therapies for rare and serious dermatologic conditions. Its primary focus lies in creating innovative treatments t..
>Volltext.. |
| 1210.53 Mio. EUR |
| 1170.14 Mio. EUR |
| - |
| - |
| - |
| - |
| 13.61 Mio. EUR |
| 53.99 Mio. EUR |
| - |
| 6.16 |
| - |
| - |
| - |
| - |
| - |
| PALVELLA |
| 25.02.26 |
|